Literature DB >> 31089954

Update in Surveillance Recommendations in Individuals With Conventional Adenomas.

Rishabh Sachdev1, Rahul Sao1, John W Birk1, Joseph C Anderson2,3, Joel Levine1,4.   

Abstract

PURPOSE OF REVIEW: Conventional adenomas, which are precursors to almost 70% of colorectal carcinomas, are found in more than one-third of screening colonoscopies. Surveillance recommendations, based on adenoma size, histology, and number, have evolved over the years and are currently reflective of index adenoma categorization as either low-risk (LRA) or high-risk (HRA). In this review, recent guideline recommendations as well as primary data that have helped to shape these recommendations are presented. RECENT
FINDINGS: Recent data have demonstrated that individuals with HRA on index exams may be at increased risk for CRC while those with LRA may have a minimal long-term risk for CRC, similar to those adults with normal index exams. Furthermore, the quality of the index exams is important for minimizing CRC risk. While individuals with HRA may require close surveillance intervals of 3 years, those with LRA or normal exams may need longer such as 10-year follow-up.

Entities:  

Keywords:  Advanced adenoma; Colorectal cancer screening; Conventional adenoma; Metachronous neoplasia; Surveillance interval

Year:  2019        PMID: 31089954     DOI: 10.1007/s11938-019-00235-4

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  51 in total

1.  Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.

Authors:  F Citarda; G Tomaselli; R Capocaccia; S Barcherini; M Crespi
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas K Rex; John H Bond; Sidney Winawer; Theodore R Levin; Randall W Burt; David A Johnson; Lynne M Kirk; Scott Litlin; David A Lieberman; Jerome D Waye; James Church; John B Marshall; Robert H Riddell
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

Review 3.  Quality indicators for colonoscopy.

Authors:  Douglas K Rex; John L Petrini; Todd H Baron; Amitabh Chak; Jonathan Cohen; Stephen E Deal; Brenda Hoffman; Brian C Jacobson; Klaus Mergener; Bret T Petersen; Michael A Safdi; Douglas O Faigel; Irving M Pike
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

4.  Quality indicators for colonoscopy and the risk of interval cancer.

Authors:  Michal F Kaminski; Jaroslaw Regula; Ewa Kraszewska; Marcin Polkowski; Urszula Wojciechowska; Joanna Didkowska; Maria Zwierko; Maciej Rupinski; Marek P Nowacki; Eugeniusz Butruk
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

5.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies.

Authors:  D K Rex; C S Cutler; G T Lemmel; E Y Rahmani; D W Clark; D J Helper; G A Lehman; D G Mark
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

6.  Impact of fair bowel preparation quality on adenoma and serrated polyp detection: data from the New Hampshire colonoscopy registry by using a standardized preparation-quality rating.

Authors:  Joseph C Anderson; Lynn F Butterly; Christina M Robinson; Martha Goodrich; Julia E Weiss
Journal:  Gastrointest Endosc       Date:  2014-05-10       Impact factor: 9.427

7.  Risk of Metachronous Advanced Neoplasia in Patients With Multiple Diminutive Adenomas.

Authors:  Jung Yoon Kim; Tae Jun Kim; Sun-Young Baek; Soohyun Ahn; Eun Ran Kim; Sung Noh Hong; Dong Kyung Chang; Young-Ho Kim
Journal:  Am J Gastroenterol       Date:  2018-08-03       Impact factor: 10.864

8.  Five-year risk of colorectal neoplasia after negative screening colonoscopy.

Authors:  Thomas F Imperiale; Elizabeth A Glowinski; Ching Lin-Cooper; Gregory N Larkin; James D Rogge; David F Ransohoff
Journal:  N Engl J Med       Date:  2008-09-18       Impact factor: 91.245

9.  Surveillance intervals after colonoscopic polypectomy.

Authors:  J D Waye; S Braunfeld
Journal:  Endoscopy       Date:  1982-05       Impact factor: 10.093

10.  Colonoscopic factors associated with adenoma detection in a national colorectal cancer screening program.

Authors:  Thomas J W Lee; Colin J Rees; Roger G Blanks; Sue M Moss; Claire Nickerson; Karen C Wright; Peter W James; Richard J Q McNally; Julietta Patnick; Matthew D Rutter
Journal:  Endoscopy       Date:  2014-01-28       Impact factor: 10.093

View more
  1 in total

1.  The enduring promise of phosphodiesterase 5 inhibitors for colon cancer prevention.

Authors:  Darren D Browning
Journal:  Transl Gastroenterol Hepatol       Date:  2019-12-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.